TrialNeuro-oncology2013

Magnetic resonance spectroscopy as an early indicator of response to anti-angiogenic therapy in patients with recurrent glioblastoma: RTOG 0625/ACRIN 6677.

Eva-Maria Ratai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.